Boston Scientific (BSX) Income from Continuing Operations (2009 - 2026)
Boston Scientific (BSX) posted quarterly Income from Continuing Operations of 905000000.0 for Q2 2026, up 13.84% year-over-year from 795000000.0 in Q2 2025, and down 32.36% on a QoQ basis from 1338000000.0 in Q1 2026.
Boston Scientific (BSX) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Boston Scientific has reported Income from Continuing Operations for 18 years, with the latest figure at 905000000.0 in Q2 2026.
- Income from Continuing Operations for Q2 2026 came in at 905000000.0, up 13.84% year-over-year; the trailing twelve-month figure through Jun 2026 was 3669000000.0 (up 46.88% YoY), and the FY2025 annual result was 2892000000.0, up 56.66% from the prior year.
- Income from Continuing Operations fell to 905000000.0 in Q2 2026, from 1338000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1338000000.0 in Q1 2026 and troughed at 111000000.0 in Q1 2022.
- A 5-year average of 515222222.22 and a median of 498500000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The widest annual swing landed in 2022, when Income from Continuing Operations tumbled 67.45%; it then surged 257.45% in 2023.
- A 5-year view of Income from Continuing Operations shows it stood at 141000000.0 in 2022, then surged by 257.45% to 504000000.0 in 2023, then grew by 11.51% to 562000000.0 in 2024, then rose by 19.22% to 670000000.0 in 2025, then jumped by 35.07% to 905000000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 905000000.0 in Q2 2026, 1338000000.0 in Q1 2026, and 670000000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 905.00 Mn |
| Mar 31, 2026 | 1.34 Bn |
| Dec 31, 2025 | 670.00 Mn |
| Sep 30, 2025 | 756.00 Mn |
| Jun 30, 2025 | 795.00 Mn |
| Mar 31, 2025 | 672.00 Mn |
| Dec 31, 2024 | 562.00 Mn |
| Sep 30, 2024 | 469.00 Mn |
| Jun 30, 2024 | 322.00 Mn |
| Mar 31, 2024 | 493.00 Mn |
| Dec 31, 2023 | 504.00 Mn |
| Sep 30, 2023 | 505.00 Mn |
| Jun 30, 2023 | 270.00 Mn |
| Mar 31, 2023 | 313.00 Mn |
| Dec 31, 2022 | 141.00 Mn |
| Sep 30, 2022 | 188.00 Mn |
| Jun 30, 2022 | 260.00 Mn |
| Mar 31, 2022 | 111.00 Mn |
| Dec 31, 2021 | 93.00 Mn |
| Sep 30, 2021 | 419.00 Mn |